Clinical trial
Different Doses of Tyrosine Adsorbed Grass Pollen Allergoid With Monophosphoryl…
NCT00133159 · Allergy Therapeutics, Industry · Completed
Key facts
| NCT number | NCT00133159 |
|---|---|
| Title | Different Doses of Tyrosine Adsorbed Grass Pollen Allergoid With Monophosphoryl Lipid A (MPL) in Patients Sensitized to Grass Pollen |
| Official title | A Double-Blind Phase IIb Study to Evaluate the Safety and Efficacy of Different Doses of Tyrosine Adsorbed Grass/Rye Pollen Allergoid With MPL in Patients Sensitized to Grass and Rye Pollen |
| Lead sponsor | Allergy Therapeutics, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Type I Hypersensitivity |
| Intervention type | Biological |
| Interventions | Grass MATAMPL |
| Enrollment | 68 |
| Start date | Sep 12, 2005 |
| Primary completion | Nov 8, 2005 |
| Completion | Nov 8, 2005 |
| First posted | Aug 23, 2005 |
| Last update posted | May 18, 2021 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: